TRS 970 - Annex 5: Development of paediatric medicines: points to consider in formulation

Annex 5, WHO Technical Report Series 970, 2012

31 December 2011
 | Technical document
TRS 970 - Annex 5: Development of paediatric medicines: points to consider in formulation
Download (197.8 kB)

Overview

General note The “points to consider” document should not contain detailed instructions for development but rather it should make reference to relevant literature. Some matters dealt with in the draft on development of multisource products have, therefore, been omitted in this proposal.
WHO Team
Access to Medicines and Health Products (MHP), Health Product Policy and Standards (HPS), Norms and Standards for Pharmaceuticals (NSP), Technical Standards and Specifications (TSS)